136 related articles for article (PubMed ID: 9047036)
21. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
[TBL] [Abstract][Full Text] [Related]
22. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
23. The effect of angiotensin II receptor antagonists on diethylstilbestrol-induced vascular changes in the rat anterior pituitary gland: a quantitative evaluation.
Pawllkowski M; Grochal M; Kulig A; Zieliński K; Stepień H; Kunert-Radek J; Mucha S
Histol Histopathol; 1996 Oct; 11(4):909-13. PubMed ID: 8930634
[TBL] [Abstract][Full Text] [Related]
24. Participation of angiotensin receptors in acute hypoxia in mice. II. Effects of angiotensin II nonpeptide receptor ligands losartan (DuP-753) and PD-123319.
Georgiev V; Opitz M
Methods Find Exp Clin Pharmacol; 1999 Sep; 21(7):463-6. PubMed ID: 10544388
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver.
García-Sáinz JA; Martínez-Alfaro M; Romero-Avila MT; González-Espinosa C
J Endocrinol; 1997 Jul; 154(1):133-8. PubMed ID: 9246947
[TBL] [Abstract][Full Text] [Related]
26. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
[TBL] [Abstract][Full Text] [Related]
27. Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity.
Catalioto RM; Renzetti AR; Criscuoli M; Mizrahi J; Subissi A
Eur J Pharmacol; 1994 Apr; 256(1):93-7. PubMed ID: 8026565
[TBL] [Abstract][Full Text] [Related]
28. Subtypes of losartan-sensitive angiotensin receptor in the rabbit pulmonary artery.
Sim MK; Chai SK
Br J Pharmacol; 1996 Apr; 117(7):1504-6. PubMed ID: 8730746
[TBL] [Abstract][Full Text] [Related]
29. Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists.
Trachte GJ; Ferrario CM; Khosla MC
J Pharmacol Exp Ther; 1990 Dec; 255(3):929-34. PubMed ID: 2262911
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
31. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors.
Raiden S; Giordano M; Andonegui G; Trevani AS; López DH; Nahmod V; Geffner JR
J Pharmacol Exp Ther; 1997 May; 281(2):624-8. PubMed ID: 9152365
[TBL] [Abstract][Full Text] [Related]
32. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
[TBL] [Abstract][Full Text] [Related]
33. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
Wong PC; Timmermans PB
Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro.
Pawlikowski M; Kunert-Radek J
Biochem Biophys Res Commun; 1997 Mar; 232(2):292-3. PubMed ID: 9125166
[TBL] [Abstract][Full Text] [Related]
35. Evidence that [Sar1]angiotensin II behaves differently from angiotensin II at angiotensin AT1 receptors in rabbit aorta.
Liu YJ
Eur J Pharmacol; 1993 Apr; 235(1):9-15. PubMed ID: 8519284
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
Hypertension; 1995 Jul; 26(1):83-8. PubMed ID: 7607737
[TBL] [Abstract][Full Text] [Related]
37. ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells.
Corriu C; André P; Schott C; Michel M; Stoclet JC
Am J Physiol; 1994 Feb; 266(2 Pt 2):H631-6. PubMed ID: 8141364
[TBL] [Abstract][Full Text] [Related]
38. Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature.
Zhuo J; Dean R; MacGregor D; Alcorn D; Mendelsohn FA
Clin Exp Pharmacol Physiol Suppl; 1996; 3():S147-54. PubMed ID: 8993855
[TBL] [Abstract][Full Text] [Related]
39. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations.
Zhang J; Pfaffendorf M; Zhang JS; Van Zwieten PA
Eur J Pharmacol; 1994 Feb; 252(3):337-40. PubMed ID: 8162955
[TBL] [Abstract][Full Text] [Related]
40. [Losartan. The first non-peptide angiotensin II receptor antagonist for treatment of hypertension].
Ibsen H; Rasmussen S; Slatanach R
Ugeskr Laeger; 1996 Jun; 158(26):3798-802. PubMed ID: 8686080
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
